NOTICE OF ALLOWANCE - ISSUED
issued
on 18 Jun 2024
Last Applicant/ Owned by
475 Green Oaks Parkway
Holly Springs
NC
27540
Serial Number
97746884 filed on 09th Jan 2023
Registration Number
N/A
Correspondent Address
Nancy Sabarra
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
SAMURAI
Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccin Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Medical services; medical information; providing a website featuring medical information
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, preparations containing messenger RNA for preventing and treating viruses and respiratory disorders; mRNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ prevention and treatment of viruses and respiratory disorders; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations for intracellular delivery of self-amplifying messenger RNA (sa-mRNA) for preventing and treating viral diseases all for pharmaceutical, medical or medical diagnostic purposes; drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; lipid nanoparticles for drug delivery sold as an integral component of drugs; pharmaceutical preparations, namely, messenger RNA and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Active biological ingredients for use in the manufacture of pharmaceuticals, namely, self-amplifying messenger RNA (sa-mRNA) encapsulated in a lipid nanoparticle composed of a cationic lipid and three helper lipids for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses and respiratory disorders; biochemicals for in vivo, ex vivo, on vivo or in vitro scientific research and medical research, namely, for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; lipid nanoparticles for scientific, laboratory or medical research use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97746884
Mark Type
No Service Mark
Attorney Docket Number
No SEQS 2301252
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 04th Dec 2024 | SOU TEAS EXTENSION RECEIVED |
| 18th Jun 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 23rd Apr 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 23rd Apr 2024 | PUBLISHED FOR OPPOSITION |
| 03rd Apr 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 15th Mar 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 11th Mar 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 11th Mar 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 11th Mar 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 12th Dec 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |